Financhill
Buy
54

AXR Quote, Financials, Valuation and Earnings

Last price:
$25.23
Seasonality move :
0.85%
Day range:
$24.84 - $26.25
52-week range:
$17.60 - $28.71
Dividend yield:
0%
P/E ratio:
12.84x
P/S ratio:
2.94x
P/B ratio:
0.98x
Volume:
9.8K
Avg. volume:
4.8K
1-year change:
-4.56%
Market cap:
$133.3M
Revenue:
$49.7M
EPS (TTM):
$1.96

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
AXR
AMREP Corp.
$14M -- 86.17% -- $23.00
AEI
Alset, Inc.
-- -- -- -- --
GCCO
Garden City Co.
-- -- -- -- --
UCASU
UC Asset LP
-- -- -- -- --
VGLS
VG Life Sciences
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
AXR
AMREP Corp.
$25.12 $23.00 $133.3M 12.84x $0.00 0% 2.94x
AEI
Alset, Inc.
$2.23 -- $86.8M -- $0.00 0% 2.95x
GCCO
Garden City Co.
$1,800.00 -- $62.8M -- $40.00 1.11% --
UCASU
UC Asset LP
$0.43 -- $2.3M 329.22x $0.00 0% 3.47x
VGLS
VG Life Sciences
$0.0001 -- $2.1M -- $0.00 0% --
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
AXR
AMREP Corp.
0.02% 1.521 0.02% 11.04x
AEI
Alset, Inc.
1.55% 2.485 2.27% 9.30x
GCCO
Garden City Co.
-- 0.394 -- --
UCASU
UC Asset LP
-- 10.279 -- --
VGLS
VG Life Sciences
-- 0.000 -- --
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
AXR
AMREP Corp.
$3.1M $1.1M 8.05% 8.06% 11.91% -$4.3M
AEI
Alset, Inc.
$242.5K -$2M -12.83% -13.18% -201.01% $822.4K
GCCO
Garden City Co.
-- -- -- -- -- --
UCASU
UC Asset LP
-- -- -- -- -- --
VGLS
VG Life Sciences
-- -- -- -- -- --

AMREP Corp. vs. Competitors

  • Which has Higher Returns AXR or AEI?

    Alset, Inc. has a net margin of 12.77% compared to AMREP Corp.'s net margin of -804.47%. AMREP Corp.'s return on equity of 8.06% beat Alset, Inc.'s return on equity of -13.18%.

    Company Gross Margin Earnings Per Share Invested Capital
    AXR
    AMREP Corp.
    32.72% $0.22 $136.1M
    AEI
    Alset, Inc.
    24.28% $0.05 $166.8M
  • What do Analysts Say About AXR or AEI?

    AMREP Corp. has a consensus price target of $23.00, signalling downside risk potential of -8.44%. On the other hand Alset, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that AMREP Corp. has higher upside potential than Alset, Inc., analysts believe AMREP Corp. is more attractive than Alset, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    AXR
    AMREP Corp.
    1 0 0
    AEI
    Alset, Inc.
    0 0 0
  • Is AXR or AEI More Risky?

    AMREP Corp. has a beta of 1.443, which suggesting that the stock is 44.267% more volatile than S&P 500. In comparison Alset, Inc. has a beta of 1.426, suggesting its more volatile than the S&P 500 by 42.563%.

  • Which is a Better Dividend Stock AXR or AEI?

    AMREP Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alset, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AMREP Corp. pays -- of its earnings as a dividend. Alset, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AXR or AEI?

    AMREP Corp. quarterly revenues are $9.4M, which are larger than Alset, Inc. quarterly revenues of $998.8K. AMREP Corp.'s net income of $1.2M is lower than Alset, Inc.'s net income of $2M. Notably, AMREP Corp.'s price-to-earnings ratio is 12.84x while Alset, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMREP Corp. is 2.94x versus 2.95x for Alset, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AXR
    AMREP Corp.
    2.94x 12.84x $9.4M $1.2M
    AEI
    Alset, Inc.
    2.95x -- $998.8K $2M
  • Which has Higher Returns AXR or GCCO?

    Garden City Co. has a net margin of 12.77% compared to AMREP Corp.'s net margin of --. AMREP Corp.'s return on equity of 8.06% beat Garden City Co.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    AXR
    AMREP Corp.
    32.72% $0.22 $136.1M
    GCCO
    Garden City Co.
    -- -- --
  • What do Analysts Say About AXR or GCCO?

    AMREP Corp. has a consensus price target of $23.00, signalling downside risk potential of -8.44%. On the other hand Garden City Co. has an analysts' consensus of -- which suggests that it could fall by --. Given that AMREP Corp. has higher upside potential than Garden City Co., analysts believe AMREP Corp. is more attractive than Garden City Co..

    Company Buy Ratings Hold Ratings Sell Ratings
    AXR
    AMREP Corp.
    1 0 0
    GCCO
    Garden City Co.
    0 0 0
  • Is AXR or GCCO More Risky?

    AMREP Corp. has a beta of 1.443, which suggesting that the stock is 44.267% more volatile than S&P 500. In comparison Garden City Co. has a beta of 0.414, suggesting its less volatile than the S&P 500 by 58.592%.

  • Which is a Better Dividend Stock AXR or GCCO?

    AMREP Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Garden City Co. offers a yield of 1.11% to investors and pays a quarterly dividend of $40.00 per share. AMREP Corp. pays -- of its earnings as a dividend. Garden City Co. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AXR or GCCO?

    AMREP Corp. quarterly revenues are $9.4M, which are larger than Garden City Co. quarterly revenues of --. AMREP Corp.'s net income of $1.2M is higher than Garden City Co.'s net income of --. Notably, AMREP Corp.'s price-to-earnings ratio is 12.84x while Garden City Co.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMREP Corp. is 2.94x versus -- for Garden City Co.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AXR
    AMREP Corp.
    2.94x 12.84x $9.4M $1.2M
    GCCO
    Garden City Co.
    -- -- -- --
  • Which has Higher Returns AXR or UCASU?

    UC Asset LP has a net margin of 12.77% compared to AMREP Corp.'s net margin of --. AMREP Corp.'s return on equity of 8.06% beat UC Asset LP's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    AXR
    AMREP Corp.
    32.72% $0.22 $136.1M
    UCASU
    UC Asset LP
    -- -- --
  • What do Analysts Say About AXR or UCASU?

    AMREP Corp. has a consensus price target of $23.00, signalling downside risk potential of -8.44%. On the other hand UC Asset LP has an analysts' consensus of -- which suggests that it could grow by 834.6%. Given that UC Asset LP has higher upside potential than AMREP Corp., analysts believe UC Asset LP is more attractive than AMREP Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    AXR
    AMREP Corp.
    1 0 0
    UCASU
    UC Asset LP
    0 0 0
  • Is AXR or UCASU More Risky?

    AMREP Corp. has a beta of 1.443, which suggesting that the stock is 44.267% more volatile than S&P 500. In comparison UC Asset LP has a beta of 3.020, suggesting its more volatile than the S&P 500 by 201.974%.

  • Which is a Better Dividend Stock AXR or UCASU?

    AMREP Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. UC Asset LP offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AMREP Corp. pays -- of its earnings as a dividend. UC Asset LP pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AXR or UCASU?

    AMREP Corp. quarterly revenues are $9.4M, which are larger than UC Asset LP quarterly revenues of --. AMREP Corp.'s net income of $1.2M is higher than UC Asset LP's net income of --. Notably, AMREP Corp.'s price-to-earnings ratio is 12.84x while UC Asset LP's PE ratio is 329.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMREP Corp. is 2.94x versus 3.47x for UC Asset LP. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AXR
    AMREP Corp.
    2.94x 12.84x $9.4M $1.2M
    UCASU
    UC Asset LP
    3.47x 329.22x -- --
  • Which has Higher Returns AXR or VGLS?

    VG Life Sciences has a net margin of 12.77% compared to AMREP Corp.'s net margin of --. AMREP Corp.'s return on equity of 8.06% beat VG Life Sciences's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    AXR
    AMREP Corp.
    32.72% $0.22 $136.1M
    VGLS
    VG Life Sciences
    -- -- --
  • What do Analysts Say About AXR or VGLS?

    AMREP Corp. has a consensus price target of $23.00, signalling downside risk potential of -8.44%. On the other hand VG Life Sciences has an analysts' consensus of -- which suggests that it could fall by --. Given that AMREP Corp. has higher upside potential than VG Life Sciences, analysts believe AMREP Corp. is more attractive than VG Life Sciences.

    Company Buy Ratings Hold Ratings Sell Ratings
    AXR
    AMREP Corp.
    1 0 0
    VGLS
    VG Life Sciences
    0 0 0
  • Is AXR or VGLS More Risky?

    AMREP Corp. has a beta of 1.443, which suggesting that the stock is 44.267% more volatile than S&P 500. In comparison VG Life Sciences has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock AXR or VGLS?

    AMREP Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VG Life Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AMREP Corp. pays -- of its earnings as a dividend. VG Life Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios AXR or VGLS?

    AMREP Corp. quarterly revenues are $9.4M, which are larger than VG Life Sciences quarterly revenues of --. AMREP Corp.'s net income of $1.2M is higher than VG Life Sciences's net income of --. Notably, AMREP Corp.'s price-to-earnings ratio is 12.84x while VG Life Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AMREP Corp. is 2.94x versus -- for VG Life Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    AXR
    AMREP Corp.
    2.94x 12.84x $9.4M $1.2M
    VGLS
    VG Life Sciences
    -- -- -- --

Related Companies

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
50
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 38x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Sell
37
Is GOOGL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Buy
59
SEZL alert for Feb 27

Sezzle, Inc. [SEZL] is down 13.92% over the past day.

Buy
83
GCT alert for Feb 27

GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.

Buy
62
LMAT alert for Feb 27

LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock